Albert Seymour, Seamless Therapeutics CEO
April 22, 2024 03:00 PM EDT
People
Startups
Cell/Gene Tx

Ex­clu­sive: Gene edit­ing start­up Seam­less hires ex-Ho­mol­o­gy leader, dou­bles seed round

Kyle LaHucik

Senior Reporter

A small Ger­man biotech at­tempt­ing to crack in­to the gene edit­ing field with an evolved ap­proach to a decades-old re­search in­ter­est has nabbed for­mer Ho­mol­o­gy …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Vi­a­tris' In­dia-based man­u­fac­tur­ing site blocked from ship­ping 11 gener­ic drugs to US

A service from the Financial Times